Venofer Dosing
For adults with iron deficiency anemia, administer Venofer (iron sucrose) 200 mg intravenously over 10 minutes as the standard bolus dose, which is both licensed and more convenient than prolonged infusions. 1
Adult Dosing by Clinical Context
Chronic Kidney Disease (CKD) - FDA Approved Regimens 2
Hemodialysis-Dependent (HDD-CKD):
- 100 mg IV undiluted over 2-5 minutes OR diluted in 100 mL 0.9% NaCl over 15 minutes
- Administer per consecutive hemodialysis session (early in dialysis, within first hour)
- Total treatment course: 1000 mg (typically 10 doses)
Non-Dialysis Dependent (NDD-CKD):
- 200 mg IV undiluted over 2-5 minutes OR diluted in 100 mL 0.9% NaCl over 15 minutes
- Give on 5 different occasions over 14 days (total 1000 mg)
- Alternative: 500 mg diluted in 250 mL 0.9% NaCl over 3.5-4 hours on Day 1 and Day 14 (limited experience)
Peritoneal Dialysis-Dependent (PDD-CKD):
- 300 mg over 1.5 hours (Day 1)
- 300 mg over 1.5 hours (Day 14)
- 400 mg over 2.5 hours (Day 28)
- Dilute in maximum 250 mL 0.9% NaCl
General Iron Deficiency Anemia (Non-CKD)
The 200 mg bolus over 10 minutes is the most practical and evidence-based approach 1. This represents a significant advantage over the traditional 2-hour infusion while maintaining safety. Multiple doses are typically required to achieve total iron repletion, with the exact number determined by calculated iron deficit.
Pediatric Dosing (≥2 Years) 2
For HDD-CKD (Iron Maintenance):
- 0.5 mg/kg (maximum 100 mg per dose)
- Every 2 weeks for 12 weeks
- Administer undiluted over 5 minutes OR diluted in 0.9% NaCl (1-2 mg/mL concentration) over 5-60 minutes
For NDD-CKD or PDD-CKD on Erythropoietin:
- 0.5 mg/kg (maximum 100 mg per dose)
- Every 4 weeks for 12 weeks
- Same administration options as above
Important Pediatric Considerations
Iron sucrose is the most studied IV iron preparation in children with rare severe adverse events 3. Studies involving 232 children receiving 1624 doses showed very few serious reactions 3. The maximum safe dose is 300 mg—the only significant adverse reaction in pediatric studies occurred when this was exceeded 3. One case report documented hepatocellular toxicity at 16 mg/kg, reinforcing the importance of dose limits 3.
Recent evidence suggests higher doses may be beneficial in critically ill children: a 2024 study found 7 mg/kg achieved 94% iron deficit replacement versus 77.5% with lower doses, with no increase in adverse events 4. However, this exceeds FDA-approved dosing and should be considered investigational.
Critical Safety Requirements
Resuscitation facilities must be immediately available for all IV iron administrations 1, 2. Anaphylaxis can occur, though Venofer has a lower risk than iron dextran (which has 0.6-0.7% serious reaction rate and documented fatalities) 1.
Monitor patients for ≥30 minutes post-infusion until clinically stable 2. Most reactions occur within 30 minutes of completion.
Do not dilute below 1 mg/mL concentration in pediatric patients 2.
Administration Technique
- Administer as slow IV push over 2-5 minutes (undiluted) OR
- Dilute in 0.9% NaCl and infuse over specified time
- For bolus dosing: 200 mg over 10 minutes is well-validated 1
- A 2005 study of 2,297 injections showed 2-minute push administration was safe with only 2.5% adverse events (excluding transient metallic taste in 17.9%) 5
Monitoring Parameters
Before treatment:
- Hemoglobin, hematocrit
- Serum ferritin
- Transferrin saturation (TSAT)
After treatment:
- Recheck at 4-8 weeks post-final dose 6, 7
- Do not check iron parameters within 4 weeks of total dose infusion—circulating iron interferes with assays 6
- Hemoglobin should increase 1-2 g/dL within 4-8 weeks 6
- In long-term PN patients, monitor regularly to prevent both deficiency and overload 3
Target values (without inflammation):
Common Pitfalls
Checking iron studies too early: Wait 48 hours minimum after dosing for serum iron, 4 weeks for ferritin/TSAT after total dose replacement 6, 2
Inadequate observation period: Most hypersensitivity reactions occur within 30 minutes—don't discharge patients prematurely 2
Exceeding maximum single doses: In children, never exceed 300 mg per dose 3; in adults, respect the 200 mg limit for bolus administration unless using approved higher-dose regimens 2
Confusing formulations: Venofer (iron sucrose) maximum single dose is 200 mg for standard bolus, unlike ferric carboxymaltose (1000 mg) or ferric derisomaltose (1500 mg) 1, 6
Iron overload: Do not administer to patients with evidence of iron overload; excessive therapy can cause iatrogenic hemosiderosis 2
Comparative Context
While Venofer requires multiple doses versus single-dose options like ferric carboxymaltose or ferric derisomaltose, it has extensive safety data and is cost-effective at £70.80 per gram of iron 1. The 12-week hemoglobin response is similar across all parenteral iron formulations 1.